Isobutyl methylxanthine, dexamethasone, insulin, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), ORO, 1,3,3-tetraethoxypropane, Nile red [9-diethylamino-5-benzo(α)phenoxazinone], and Griess reagent were purchased from Sigma (St. Louis, MO, USA). RNAiso Plus, PrimeScript first-strand complementary DNA (cDNA) synthesis kit, and SYBR Premix Ex Taq real-time PCR kit were purchased from Takara Bio Inc. (Otsu, Shiga, Japan). Antibodies against PPARγ, CCAAT/enhancer-binding protein-alpha (C/EBPα), phospho-Akt (Ser473), and Akt were purchased from Cell Signaling Technology (Danvers, MA, USA). Primary antibody for β-actin was obtained from Sigma. Horseradish peroxidase (HRP)-conjugated antimouse and antirabbit immunoglobulin G (IgG) antibodies were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Extracts of SG, RG, and WG were provided by Ginseng Science Inc. (Seoul, Korea).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.